Patents by Inventor Lichun Dong

Lichun Dong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9205146
    Abstract: This invention relates to therapeutic compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The methods are particularly effective for protecting mammals from herpes simplex virus.
    Type: Grant
    Filed: September 12, 2014
    Date of Patent: December 8, 2015
    Assignees: Vical Incorporated, THE UNIVERSITY OF WASHINGTON
    Inventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David M. Koelle
  • Patent number: 9161973
    Abstract: This invention relates to therapeutic polynucleotide compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The polynucleotide compositions are particularly effective for protecting mammals from herpes simplex virus (HSV), such as HSV gD2 polypeptides.
    Type: Grant
    Filed: August 14, 2014
    Date of Patent: October 20, 2015
    Assignees: Vical Incorporated, UNIVERSITY OF WASHINGTON
    Inventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David M. Koelle
  • Publication number: 20150030631
    Abstract: This invention relates to therapeutic compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The methods are particularly effective for protecting mammals from herpes simplex virus.
    Type: Application
    Filed: October 3, 2014
    Publication date: January 29, 2015
    Applicants: VICAL INCORPORATED, The University of Washington
    Inventors: ADRIAN VILALTA, MICHAL MARGALITH, LICHUN DONG, DAVID M. KOELLE
  • Publication number: 20150010596
    Abstract: This invention relates to therapeutic compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The methods are particularly effective for protecting mammals from herpes simplex virus.
    Type: Application
    Filed: September 12, 2014
    Publication date: January 8, 2015
    Applicants: Vical Incorporated, The University of Washington
    Inventors: Adrian VILALTA, Michal Margalith, Lichun Dong, David M. Koelle
  • Publication number: 20150010597
    Abstract: This invention relates to therapeutic polynucleotide compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The polynucleotide compositions are particularly effective for protecting mammals from herpes simplex virus (HSV), such as HSV gD2, VP11/12, and VP13/14 polypeptides.
    Type: Application
    Filed: September 17, 2014
    Publication date: January 8, 2015
    Applicants: Vical Incorporated, The University Of Washington
    Inventors: Adrian VILALTA, Michal Margalith, Lichun Dong, David M. Koelle
  • Publication number: 20140370055
    Abstract: This invention relates to therapeutic polynucleotide compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The polynucleotide compositions are particularly effective for protecting mammals from herpes simplex virus (HSV), such as HSV gD2 polypeptides.
    Type: Application
    Filed: August 14, 2014
    Publication date: December 18, 2014
    Applicants: Vical Incorporated, THE UNIVERSITY OF WASHINGTON
    Inventors: Adrian VILALTA, Michal Margalith, Lichun Dong, David M. Koelle
  • Patent number: 8852611
    Abstract: This invention relates to therapeutic compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The methods are particularly effective for protecting mammals from herpes simplex virus.
    Type: Grant
    Filed: August 14, 2012
    Date of Patent: October 7, 2014
    Assignees: Vical Incorporated, The University of Washington
    Inventors: Adrian Vilalta, Michal Maragalith, Lichun Dong, David M. Koelle
  • Patent number: 8852610
    Abstract: This invention relates to therapeutic compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The methods are particularly effective for protecting mammals from herpes simplex virus.
    Type: Grant
    Filed: August 14, 2012
    Date of Patent: October 7, 2014
    Assignees: Vical Incorporated, The University of Washington
    Inventors: Adrian Vilalta, Michal Maragalith, Lichun Dong, David M. Koelle
  • Patent number: 8840904
    Abstract: This invention relates to therapeutic polynucleotide compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The polynucleotide compositions are particularly effective for protecting mammals from herpes simplex virus (HSV), such as HSV VP11/12 polypeptides.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: September 23, 2014
    Assignees: Vical Incorporated, The University of Washington
    Inventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David M. Koelle
  • Patent number: 8840903
    Abstract: This invention relates to therapeutic polynucleotide compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The polynucleotide compositions are particularly effective for protecting mammals from herpes simplex virus (HSV), such as HSV gD2, VP11/12, and VP13/14 polypeptides.
    Type: Grant
    Filed: August 9, 2012
    Date of Patent: September 23, 2014
    Assignee: Vical Incorporated
    Inventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David M. Koelle
  • Patent number: 8834894
    Abstract: This invention relates to therapeutic polynucleotide compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The polynucleotide compositions are particularly effective for protecting mammals from herpes simplex virus (HSV), such as HSV gD2 polypeptides.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: September 16, 2014
    Assignees: Vical Incorporated, The University of Washington
    Inventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David M. Koelle
  • Patent number: 8828408
    Abstract: This invention relates to therapeutic polynucleotide compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The polynucleotide compositions are particularly effective for protecting mammals from herpes simplex virus (HSV), such as HSV VP13/14 polypeptides.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: September 9, 2014
    Assignees: Vical Incorporated, The University of Washington
    Inventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David M. Koelle
  • Publication number: 20130273108
    Abstract: This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.
    Type: Application
    Filed: March 15, 2013
    Publication date: October 17, 2013
    Inventors: ADRIAN VILALTA, MICHAL MARGALITH, LICHUN DONG, DAVID M. KOELLE
  • Publication number: 20130273107
    Abstract: This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.
    Type: Application
    Filed: March 15, 2013
    Publication date: October 17, 2013
    Inventors: ADRIAN VILALTA, MICHAL MARGALITH, LICHUN DONG, DAVID M. KOELLE
  • Publication number: 20120328658
    Abstract: This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.
    Type: Application
    Filed: August 14, 2012
    Publication date: December 27, 2012
    Applicants: THE UNIVERSITY OF WASHINGTON, Vical Incorporated
    Inventors: Adrian VILALTA, Michal Maragalith, Lichun Dong, David M. Koelle
  • Publication number: 20120328656
    Abstract: This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.
    Type: Application
    Filed: August 9, 2012
    Publication date: December 27, 2012
    Applicants: THE UNIVERSITY OF WASHINGTON, Vical Incorporated
    Inventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David M. Koelle
  • Publication number: 20120328657
    Abstract: This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.
    Type: Application
    Filed: August 14, 2012
    Publication date: December 27, 2012
    Applicants: THE UNIVERSITY OF WASHINGTON, Vical Incorporated
    Inventors: Adrian VILALTA, Michal Margalith, Lichun Dong, David M. Koelle
  • Patent number: 8293248
    Abstract: This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.
    Type: Grant
    Filed: October 16, 2009
    Date of Patent: October 23, 2012
    Assignees: Vical Incorporated, The University of Washington
    Inventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David Koelle
  • Patent number: 8263087
    Abstract: This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.
    Type: Grant
    Filed: October 23, 2009
    Date of Patent: September 11, 2012
    Assignees: Vical Incorporated, The University of Washington
    Inventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David M. Koelle
  • Patent number: 7935352
    Abstract: This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.
    Type: Grant
    Filed: October 16, 2009
    Date of Patent: May 3, 2011
    Assignees: Vical Incorporated, The University of Washington
    Inventors: Adrian Vilalta, Michal Margalith, Lichun Dong, David Koelle